WeedMD Inc. (“
WeedMD” or the
“
Company”) (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE), a
federally-licensed producer and distributor of medical-grade
cannabis, is pleased to announce that it has entered into an
amended letter of engagement with Eight Capital, under which Eight
Capital has now agreed to purchase, as joint bookrunner and co-lead
underwriter along with Canaccord Genuity Corp. (the
“
Co-Lead Underwriters”), 21,342,000 units of the
Company (the “
Units”), on a “bought deal” basis
pursuant to a filing of a short form prospectus, subject to all
required regulatory approvals, at a price per Unit of $0.82 (the
“
Issue Price”) for gross proceeds of $17,500,440
(the “
Offering”).
The Company has agreed to grant Eight Capital an
over-allotment option to purchase up to an additional 15% of the
Units at the Issue Price, exercisable in whole or in part, at any
time on or prior to the date that is 30 days following the closing
of the Offering. If this option is exercised in full, an additional
approximately $2,625,000 will be raised pursuant to the Offering
and the aggregate proceeds of the Offering will be approximately
$20,125,000.
Each Unit will be comprised of one common share
of the Company (a “Common Share”) and one-half of
one Common Share purchase warrant (each whole warrant,
“Warrant”). Each Warrant shall entitle the holder
thereof to purchase one Common Share at an exercise price of $1.00,
for a period of 24 months following the closing of the Offering.
If, after the one-year anniversary of the closing of the Offering,
the daily volume weighted average trading price of the Shares on
the TSX Venture Exchange for any 10 consecutive days equals or
exceeds $1.64, the Company may, upon providing written notice to
the holders of the Warrants, accelerate the expiry date of the
Warrants to the date that is 30 days following the date of such
written notice.
The Company intends to use the net proceeds of
the Offering for working capital and general corporate
purposes.
The closing date of the Offering is scheduled to
be on or about March 4, 2021 and is subject to certain conditions
including, but not limited to, the receipt of all necessary
approvals, including the approval of the applicable securities
regulatory authorities.
This press release shall not constitute an offer
to sell or the solicitation of an offer to buy nor shall there be
any sale of the securities in any state in which such offer,
solicitation or sale would be unlawful. The securities being
offered have not been, nor will they be, registered under the
United States Securities Act of 1933, as amended, and may not be
offered or sold in the United States absent registration or an
applicable exemption from the registration requirements of the
United States Securities Act of 1933, as amended, and applicable
state securities laws.
About WeedMD Inc.
WeedMD Inc. is the publicly traded parent
company of WeedMD RX Inc. and Starseed Medicinal Inc., licence
holders producing and distributing cannabis products for both the
medical and adult-use markets. The Company owns and operates a
158-acre state-of-the-art greenhouse, outdoor and processing
facility located in Strathroy, ON as well as a fully-licensed
26,000 sq. ft. Aylmer, ON processing facility, specializing in
cannabis extraction. With the addition of Starseed, a
medical-centric operator, WeedMD has expanded its multi-channeled
distribution strategy. Starseed’s industry-first, exclusive
partnership with LiUNA, the largest construction union in Canada,
along with employers and union groups complements WeedMD’s direct
sales to medical patients. The Company maintains strategic
relationships in the seniors’ market and supply agreements with
Shoppers Drug Mart as well, as seven provincial distribution
agencies where adult-use brands Color Cannabis and Saturday are
sold.
For further information, please
contact:
For Investor Enquiries: Valter
Pinto Managing Director KCSA Strategic Communications
1-212-896-1254 weedmd@kcsa.com
For Media Enquiries: Marianella
delaBarrera VP, Communications & Corporate Affairs 416-897-6644
marianella@weedmd.com
Forward Looking Information
This press release contains "forward-looking
information" within the meaning of applicable Canadian securities
legislation which are based upon WeedMD's current internal
expectations, estimates, projections, assumptions and beliefs and
views of future events. Forward-looking information can be
identified by the use of forward-looking terminology such as
"expect", "likely", "may", "will", "should", "intend",
"anticipate", "potential", "proposed", "estimate" and other similar
words, including negative and grammatical variations thereof, or
statements that certain events or conditions "may", "would" or
"will" happen, or by discussions of strategy. The forward-looking
information in this news release is based upon the expectations,
estimates, projections, assumptions and views of future events
which management believes to be reasonable in the circumstances.
Forward-looking information includes estimates, plans,
expectations, opinions, forecasts, projections, targets, guidance
or other statements that are not statements of fact.
Forward-looking information in this news release include, but are
not limited to, statements with respect to the closing of the
Offering on or about March 4, 2021, the exercise of the
over-allotment option and the use of proceeds of the Offering.
Forward-looking information necessarily involve known and unknown
risks, including, without limitation, risks associated with general
economic conditions; adverse industry events; loss of markets;
future legislative and regulatory developments; the cannabis
industry in Canada generally; the ability of WeedMD to implement
its business strategies; the COVID-19 pandemic; competition; crop
failure; and other risks. Any forward-looking information speaks
only as of the date on which it is made, and, except as required by
law, WeedMD does not undertake any obligation to update or revise
any forward-looking information, whether as a result of new
information, future events or otherwise. New factors emerge from
time to time, and it is not possible for WeedMD to predict all such
factors. When considering this forward-looking information, readers
should keep in mind the risk factors and other cautionary
statements in WeedMD's disclosure documents filed with the
applicable Canadian securities regulatory authorities on SEDAR at
www.sedar.com. The risk factors and other factors noted in the
disclosure documents could cause actual events or results to differ
materially from those described in any forward-looking
information.
NEITHER THE TSX VENTURE EXCHANGE NOR ITS
REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE
POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR
THE ADEQUACY OR ACCURACY OF THIS RELEASE.
WeedMD (TSXV:WMD)
Historical Stock Chart
From Nov 2024 to Dec 2024
WeedMD (TSXV:WMD)
Historical Stock Chart
From Dec 2023 to Dec 2024